Dumont FJ et al. |
Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. |
1990 |
J. Immunol. |
pmid:1688572
|
Li PK et al. |
The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506. |
1990 |
Adverse Drug React Acute Poisoning Rev |
pmid:1703724
|
Jain AB et al. |
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. |
1990 |
Transplant. Proc. |
pmid:1689900
|
Fung JJ et al. |
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. |
1990 |
Transplant. Proc. |
pmid:1689901
|
Zeevi A et al. |
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. |
1990 |
Transplant. Proc. |
pmid:1689902
|
Imventarza O et al. |
Renal transplantation in baboons under FK 506. |
1990 |
Transplant. Proc. |
pmid:1689903
|
Monden M et al. |
A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates. |
1990 |
Transplant. Proc. |
pmid:1689904
|
Ericzon BG et al. |
Pancreaticoduodenal allotransplantation with FK 506 in the cynomolgus monkey. |
1990 |
Transplant. Proc. |
pmid:1689905
|
Murase N et al. |
Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689906
|
Hoffman AL et al. |
The effect of FK 506 on small intestine allotransplantation in the rat. |
1990 |
Transplant. Proc. |
pmid:1689907
|
Lee KK et al. |
Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. |
1990 |
Transplant. Proc. |
pmid:1689908
|
Ueda Y et al. |
Induction of graft acceptance after dog kidney or liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689909
|
Tze WJ et al. |
In vitro effects of FK-506 on human and rat islets. |
1990 |
Transplantation |
pmid:1694319
|
Maki N et al. |
Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin. |
1990 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1695378
|
Doe SE et al. |
Early effects of the immunosuppressive drug FK-506 on signal transduction in lymphocytes. |
1990 |
Biochem. Soc. Trans. |
pmid:1695581
|
Murase N et al. |
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. |
1990 |
Transplantation |
pmid:1696405
|
Propper DJ et al. |
FK506--its influence on anti-class 1 MHC alloantibody responses to blood transfusions. |
1990 |
Transplantation |
pmid:1696409
|
Maruyama M et al. |
Effect of FK506 treatment on allocytolytic T lymphocyte induction in vivo: differential effects of FK506 on L3T4+ and Ly2+ T cells. |
1990 |
Transplantation |
pmid:1696410
|
Standaert RF et al. |
Molecular cloning and overexpression of the human FK506-binding protein FKBP. |
1990 |
Nature |
pmid:1696686
|
Tropschug M et al. |
Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding. |
1990 |
Nature |
pmid:1696687
|
Randall T |
New antirejection drugs anticipated. |
1990 |
JAMA |
pmid:1696999
|
Metcalfe S et al. |
FK 506 and cyclosporine A: early effects on activation and gene induction in mouse spleen cells. |
1990 |
Transplant. Proc. |
pmid:1697107
|
Morris RE et al. |
A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection. |
1990 |
Transplant. Proc. |
pmid:1697111
|
Takai K et al. |
Effects of FK506 on rat thymus: time-course analysis by immunoperoxidase technique and flow cytofluorometry. |
1990 |
Clin. Exp. Immunol. |
pmid:1702372
|
Okubo Y et al. |
FK506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis. |
1990 |
Clin. Exp. Immunol. |
pmid:1702373
|
Arita C et al. |
Inhibition by FK506 of established lesions of collagen-induced arthritis in rats. |
1990 |
Clin. Exp. Immunol. |
pmid:1702374
|
Woo J et al. |
Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion. |
1990 |
Clin. Exp. Immunol. |
pmid:1702375
|
Mattila PS et al. |
The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. |
1990 |
EMBO J. |
pmid:1702384
|
Kawashima H et al. |
Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat. |
1990 |
Invest. Ophthalmol. Vis. Sci. |
pmid:1702408
|
Wilkinson PC and Watson EA |
FK506 and pertussis toxin distinguish growth-induced locomotor activation from attractant-stimulated locomotion in human blood lymphocytes. |
1990 |
Immunology |
pmid:1702750
|
Metcalfe S and Milner J |
Phosphatases PP1 and PP2A act after the G0/G1 interface in lymphocyte activation. |
1990 |
Immunol. Lett. |
pmid:1702753
|
Takada K et al. |
Determination of a novel potent immunosuppressant (FK-506) in rat serum and lymph by high-performance liquid chromatography with chemiluminescence detection. |
1990 |
J. Chromatogr. |
pmid:1703552
|
Fung JJ et al. |
Overview of FK506 in transplantation. |
1990 |
Clin Transpl |
pmid:1715740
|
Collier SJ |
Immunosuppressive drugs. |
1989-1990 |
Curr. Opin. Immunol. |
pmid:2484794
|
McCauley J et al. |
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. |
1989 Dec 23-30 |
Lancet |
pmid:2481200
|
Takabayashi K et al. |
Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus. |
1989 |
Clin. Immunol. Immunopathol. |
pmid:2466594
|
Morris RE et al. |
Immunopharmacology of FK-506. |
1989 |
Transplant. Proc. |
pmid:2468201
|
Yoshimura N et al. |
A new immunosuppressive agent, FK506, inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity. |
1989 |
Transplant. Proc. |
pmid:2468202
|
Thomson AW et al. |
Immunosuppressive activity, T-cell subset analysis, and acute toxicity of FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468203
|
Sanghvi A et al. |
Increased cyclosporine uptake by cells pretreated with FK506 and evidence for binding of both drugs to a common intracellular protein. |
1989 |
Transplant. Proc. |
pmid:2468204
|
Takagishi K et al. |
Effects of FK-506 on collagen arthritis in mice. |
1989 |
Transplant. Proc. |
pmid:2468205
|
Arita C et al. |
Effect of FK 506 (FR 900506) on collagen arthritis in rats: a preliminary report. |
1989 |
Transplant. Proc. |
pmid:2468206
|
Morimoto T et al. |
Blood levels of FK506 after intramuscular and intravenous administration in dogs. |
1989 |
Transplant. Proc. |
pmid:2468207
|
Thomson AW and Woo J |
Immunosuppressive properties of FK-506 and rapamycin. |
1989 |
Lancet |
pmid:2474733
|
Todo S et al. |
Renal transplantation in baboons under FK 506. |
1989 |
Surgery |
pmid:2474865
|
Kay JE et al. |
Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506. |
1989 |
Immunology |
pmid:2475433
|
Moriyama S |
[Experimental tracheal reconstruction by allotransplantation]. |
1989 |
Nihon Kyobu Geka Gakkai Zasshi |
pmid:2475555
|
Freedman RB |
Immunosuppression. Convergence of drug action. |
1989 |
Nature |
pmid:2477712
|
Siekierka JJ et al. |
A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. |
1989 |
Nature |
pmid:2477714
|
Harding MW et al. |
A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. |
1989 |
Nature |
pmid:2477715
|